搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
aqst
/
财务摘要
Aquestive Therapeutics Inc
AQST
添加自选
4.780
USD
+0.170
+3.69%
收盘 09-18 16:00(美东)
598.69M
总市值
亏损
市盈率 TTM
Aquestive Therapeutics Inc
4.780
+0.170
+3.69%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
AQST 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Aquestive Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
598.69M
股息TTM
0.00
市盈率 TTM
-7.83
每股收益TTM
-0.61
营业收入
44.55M
净利润
-44.14M
净资产收益率
0.00%
总资产收益率
-56.63%
Aquestive Therapeutics Inc 财报日历
最新发布
8月 11, 2026
每股收益 / 预测值
-0.18
/-0.10
营业收入 / 预测值
13.82M
/11.42M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-34.11%
-0.18
72.63%
-0.07
-39.54%
-0.26
-10.54%
-0.14
-351.81%
-0.14
-37.79%
-0.24
-55.03%
-0.19
-301.65%
-0.13
70.11%
-0.03
-220.16%
-0.17
46.84%
-0.12
--
-0.03
--
-0.10
--
0.15
--
-0.23
--
-0.90
--
--
--
--
--
--
--
--
营业收入
38.15%
13.82M
65.67%
14.45M
9.67%
13.02M
-5.43%
12.81M
-50.23%
10.00M
-27.65%
8.72M
-10.14%
11.87M
4.15%
13.54M
51.79%
20.10M
8.25%
12.05M
23.63%
13.21M
13.43%
13.00M
-0.18%
13.24M
-9.26%
11.13M
-3.57%
10.68M
-13.73%
11.46M
-13.55%
13.27M
10.32%
12.27M
54.96%
11.08M
60.86%
13.29M
净利润
-68.76%
-22.86M
64.86%
-8.06M
-86.81%
-31.86M
-34.21%
-15.45M
-393.55%
-13.55M
-78.75%
-22.93M
-110.27%
-17.05M
-465.55%
-11.51M
52.61%
-2.75M
-259.00%
-12.83M
34.33%
-8.11M
83.77%
-2.04M
64.47%
-5.79M
161.03%
8.07M
57.33%
-12.35M
13.87%
-12.54M
-31.82%
-16.30M
9.90%
-13.22M
-42.11%
-28.95M
12.06%
-14.55M
利润率
-22.16%
-165.45%
78.79%
-55.77%
-70.33%
-244.79%
-41.91%
-120.61%
-891.69%
-135.44%
-147.07%
-262.96%
-134.00%
-143.72%
-443.00%
-84.99%
68.78%
-13.66%
-246.88%
-106.43%
46.88%
-61.42%
--
-15.65%
--
-43.74%
--
72.46%
--
-115.63%
--
-113.68%
--
--
--
--
--
--
--
--
毛利率
30.38%
70.93%
30.74%
75.99%
-10.91%
55.16%
-3.60%
64.82%
-29.78%
54.40%
-8.60%
58.12%
-4.12%
61.91%
6.56%
67.24%
54.88%
77.48%
10.67%
63.59%
28.27%
64.57%
--
63.10%
--
50.03%
--
57.45%
--
50.34%
--
61.94%
--
--
--
--
--
--
--
--
资产负债率
185.05%
106.54%
176.18%
91.24%
145.84%
78.84%
165.99%
75.66%
46.37%
37.38%
48.66%
33.03%
-33.11%
32.07%
-56.82%
28.45%
-62.84%
25.53%
-67.87%
22.22%
-47.53%
47.95%
--
65.87%
--
68.71%
--
69.17%
--
91.38%
--
102.03%
--
--
--
--
--
--
--
--
利润表
营业收入
38.15%
13.82M
65.67%
14.45M
9.67%
13.02M
-5.43%
12.81M
-50.23%
10.00M
-27.65%
8.72M
-10.14%
11.87M
4.15%
13.54M
51.79%
20.10M
8.25%
12.05M
23.63%
13.21M
13.43%
13.00M
-0.18%
13.24M
-9.26%
11.13M
-3.57%
10.68M
-13.73%
11.46M
-13.55%
13.27M
10.32%
12.27M
54.96%
11.08M
60.86%
13.29M
营业利润
27.67%
-8.22M
78.29%
-4.20M
-112.38%
-28.84M
-38.47%
-11.48M
-20769.09%
-11.37M
-116.20%
-19.36M
-247.20%
-13.58M
-248.76%
-8.29M
101.31%
55.00K
-94.51%
-8.96M
63.49%
-3.91M
73.15%
-2.38M
67.02%
-4.21M
52.71%
-4.61M
8.19%
-10.71M
-11.11%
-8.85M
-95.83%
-12.76M
-14.23%
-9.74M
25.42%
-11.67M
42.18%
-7.97M
净利润
-68.76%
-22.86M
64.86%
-8.06M
-86.81%
-31.86M
-34.21%
-15.45M
-393.55%
-13.55M
-78.75%
-22.93M
-110.27%
-17.05M
-465.55%
-11.51M
52.61%
-2.75M
-259.00%
-12.83M
34.33%
-8.11M
83.77%
-2.04M
64.47%
-5.79M
161.03%
8.07M
57.33%
-12.35M
13.87%
-12.54M
-31.82%
-16.30M
9.90%
-13.22M
-42.11%
-28.95M
12.06%
-14.55M
资产负债表
流动资产
45.00%
118.49M
46.00%
130.18M
69.20%
149.27M
57.06%
151.67M
-21.43%
81.72M
-21.35%
89.17M
115.35%
88.22M
127.45%
96.57M
161.41%
104.01M
159.41%
113.38M
2.70%
40.97M
11.47%
42.46M
-8.54%
39.79M
2.63%
43.71M
-15.60%
39.89M
-24.14%
38.09M
-14.69%
43.51M
-4.18%
42.59M
5.90%
47.26M
58.47%
50.21M
流动负债总额
-28.84%
16.48M
73.53%
31.75M
152.36%
47.61M
68.78%
25.57M
66.64%
23.16M
1.33%
18.30M
3.04%
18.86M
-37.02%
15.15M
-64.05%
13.89M
-55.28%
18.06M
-53.68%
18.31M
-34.20%
24.06M
30.43%
38.65M
66.98%
40.38M
79.97%
39.53M
46.01%
36.56M
28.66%
29.64M
20.62%
24.18M
4.08%
21.96M
36.28%
25.04M
总资产
40.99%
132.10M
38.04%
141.13M
58.17%
160.43M
48.75%
163.56M
-20.33%
93.70M
-21.07%
102.23M
76.64%
101.42M
84.97%
109.96M
106.35%
117.61M
111.35%
129.52M
0.61%
57.42M
14.66%
59.45M
1.21%
56.99M
8.41%
61.28M
-7.94%
57.07M
-20.60%
51.84M
-15.80%
56.31M
-8.71%
56.53M
-1.42%
61.99M
29.49%
65.29M
总负债
13.47%
188.69M
7.36%
175.18M
20.12%
194.09M
7.91%
167.67M
8.63%
166.29M
-1.60%
163.16M
-1.42%
161.58M
-4.31%
155.38M
-6.45%
153.08M
-2.75%
165.82M
-6.67%
163.91M
1.70%
162.38M
7.19%
163.65M
13.93%
170.52M
21.85%
175.62M
27.08%
159.66M
26.54%
152.67M
31.61%
149.67M
29.40%
144.13M
44.51%
125.64M
总权益
22.05%
-56.59M
44.11%
-34.05M
44.04%
-33.66M
90.95%
-4.11M
-104.60%
-72.59M
-67.85%
-60.93M
43.51%
-60.16M
55.87%
-45.42M
66.73%
-35.48M
66.77%
-36.30M
10.18%
-106.49M
4.54%
-102.93M
-10.68%
-106.65M
-17.28%
-109.23M
-44.34%
-118.55M
-78.67%
-107.82M
-79.21%
-96.36M
-79.82%
-93.14M
-69.36%
-82.13M
-65.24%
-60.34M
现金流量表
经营净额
-19.29%
-9.44M
36.73%
-14.81M
-30.51%
-8.47M
-6.47%
-12.65M
-12.96%
-7.91M
-125.35%
-23.40M
-31.30%
-6.49M
-406.18%
-11.88M
11.39%
-7.01M
-217.79%
-10.38M
-158.51%
-4.94M
-183.55%
-2.35M
-20.50%
-7.91M
160.88%
8.82M
204.78%
8.45M
130.99%
2.81M
-273.69%
-6.56M
-2.73%
-14.48M
40.34%
-8.06M
-9.05%
-9.06M
投资净额
-98.13%
-212.00K
61.48%
-52.00K
-466.67%
-85.00K
-193.75%
-235.00K
-205.71%
-107.00K
-365.52%
-135.00K
6.25%
-15.00K
47.02%
-80.00K
95.76%
-35.00K
-1350.00%
-29.00K
38.46%
-16.00K
91.21%
-151.00K
-22.01%
-826.00K
98.08%
-2.00K
95.12%
-26.00K
-1968.67%
-1.72M
-248.97%
-677.00K
-0.97%
-104.00K
-125.85%
-533.00K
-118.42%
-83.00K
融资净额
-2491.00%
-2.59M
-78.58%
4.42M
320.38%
660.00K
478988.24%
81.41M
-105.84%
-100.00K
-74.74%
20.65M
-95.99%
157.00K
-100.34%
-17.00K
-60.09%
1.71M
988.01%
81.74M
1818.14%
3.91M
3707.97%
4.98M
-57.96%
4.29M
-809.17%
-9.21M
-96.26%
204.00K
-102.27%
-138.00K
17.41%
10.20M
-86.88%
1.30M
-80.86%
5.45M
86928.57%
6.08M
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Aquestive Therapeutics Inc的总收入是多少?
根据Aquestive Therapeutics Inc的FY2025财报,总收入达到了44.55M(同比变化57.56M)。
Aquestive Therapeutics Inc的流动资产是多少?
根据Aquestive Therapeutics Inc的FY2025财报,流动资产为149.27M(同比变化69.20)。
Aquestive Therapeutics Inc的总资产是多少?
根据Aquestive Therapeutics Inc的FY2025财报,Aquestive Therapeutics Inc的总资产为160.43M(同比变化58.17)。
Aquestive Therapeutics Inc的总负债是多少?
根据Aquestive Therapeutics Inc的FY2025财报,Aquestive Therapeutics Inc的总负债为194.09M(同比变化20.12)。
Aquestive Therapeutics Inc的总权益是多少?
根据Aquestive Therapeutics Inc的FY2025财报,Aquestive Therapeutics Inc的总权益为-33.66M(同比变化44.04)。
Aquestive Therapeutics Inc的净营业收入是多少?
根据Aquestive Therapeutics Inc的FY2025财报,Aquestive Therapeutics Inc的净营业收入为-71.05M(同比变化-130.90)。
Aquestive Therapeutics Inc的净投资是多少?
根据Aquestive Therapeutics Inc的FY2025财报,Aquestive Therapeutics Inc的净投资为-562.00K(同比变化-253.46)。
Aquestive Therapeutics Inc的净融资是多少?
根据Aquestive Therapeutics Inc的FY2025财报,Aquestive Therapeutics Inc的净融资为102.62M(同比变化22.76)。
Aquestive Therapeutics Inc的每股收益(EPS)是多少?
根据Aquestive Therapeutics Inc的FY2025财报,每股收益(EPS)为-0.78(同比变化-53.97)。
Aquestive Therapeutics Inc的净利润是多少?
根据Aquestive Therapeutics Inc的FY2025财报,净利润为-83.78M(同比变化-89.83)。
Aquestive Therapeutics Inc的净利润率是多少?
根据Aquestive Therapeutics Inc的FY2025财报,净利润率为-188.09(同比变化-145.29)。
Aquestive Therapeutics Inc的毛利率是多少?
根据Aquestive Therapeutics Inc的FY2025财报,毛利率为58.35(同比变化-15.38)。
Aquestive Therapeutics Inc的债务与资产比率是多少?
根据Aquestive Therapeutics Inc的FY2025财报,债务与资产比率为78.84(同比变化-31.34)。
Aquestive Therapeutics Inc的资产回报率(ROA)是多少?
根据Aquestive Therapeutics Inc的FY2025财报,资产回报率(ROA)为-63.99(同比变化-15.15)。
Aquestive Therapeutics Inc的营业利润是多少?
根据Aquestive Therapeutics Inc的FY2025财报,营业利润为-71.05M(同比变化-130.90)。